Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 45, Issue , 2013, Pages 170-177

  Sánchez, Maria Gabriela ^a,b   Morissette, Marc ^a,b   Di Paolo, Thérèse ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Brain; Estradiol; Monkey; MPTP; Serotonin reuptake transporter

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CITALOPRAM; ESTRADIOL; LEVODOPA; RADIOLIGAND; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG BINDING; FEMALE; HEMISPHERE; MACACA FASCICULARIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OVARIECTOMY; PARKINSONISM; PUTAMEN; RAPHE NUCLEUS; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 5-HT; BRAIN; DA; DOPAMINE; ESTRADIOL; MONKEY; MPTP; OVARIECTOMIZED; OVX; PARKINSON DISEASE; PD; SEROTONIN; SEROTONIN REUPTAKE TRANSPORTER; SERT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; CITALOPRAM; ESTRADIOL; FEMALE; MACACA FASCICULARIS; MICROINJECTIONS; OVARIECTOMY; PARKINSONIAN DISORDERS; POSTMENOPAUSE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANTIA NIGRA; TRITIUM;

EID: 84879376750     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.05.008     Document Type: Article

References (36)

1. Albin R.L., Koeppe R.A., Bohnen N.I., Wernette K., Kilbourn M.A., Frey K.A. Spared caudal brainstem SERT binding in early Parkinson's disease. J Cereb Blood Flow Metab 2008, 28:441-444.
2. Bedard C., Wallman M.J., Pourcher E., Gould P.V., Parent A., Parent M. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea. Parkinsonism Relat Disord 2011, 17:593-598.
3. Bethea C.L., Smith A.W., Centeno M.L., Reddy A.P. Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 2011, 192:675-688.
4. Boileau I., Warsh J.J., Guttman M., Saint-Cyr J.A., McCluskey T., Rusjan P., et al. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Mov Disord 2008, 23:1776-1780.
5. Carta M., Carlsson T., Kirik D., Bjorklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833.
6. Guttman M., Boileau I., Warsh J., Saint-Cyr J.A., Ginovart N., McCluskey T., et al. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur J Neurol 2007, 14:523-528.
7. Halliday G.M., Blumbergs P.C., Cotton R.G., Blessing W.W., Geffen L.B. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1990, 510:104-107.
8. Hornung J.P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003, 26:331-343.
9. Jellinger K.A., Paulus W. Clinico-pathological correlations in Parkinson's disease. Clin Neurol Neurosurg 1992, 94:S86-S88. [Suppl.].
10. Kerenyi L., Ricaurte G.A., Schretlen D.J., McCann U., Varga J., Mathews W.B., et al. Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol 2003, 60:1223-1229.
11. Kish S.J., Tong J., Hornykiewicz O., Rajput A., Chang L.J., Guttman M., et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008, 131:120-131.
12. Lu N.Z., Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
13. Lu N.Z., Eshleman A.J., Janowsky A., Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Mol Psychiatry 2003, 8:353-360.
14. Maeda T., Nagata K., Yoshida Y., Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered L-DOPA. Brain Res 2005, 1046:230-233.
15. Martin R.F., Bowden D.M. Primate brain maps: structure of the macaque brain 2000, 1-160. Elsevier Science, Amsterdam.
16. Mayeux R. The "serotonin hypothesis" for depression in Parkinson's disease. Adv Neurol 1990, 53:163-166.
17. Meyer J.H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007, 32:86-102.
18. Morissette M., Di Paolo T. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys. J Neurosci Res 2009, 87:1634-1644.
19. Murthy V., Martin T.J., Kim S., Davies H.M., Childers S.R. In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain. J Pharmacol Exp Ther 2008, 326:587-595.
20. Navailles S., De Deurwaerdere P. Imbalanced dopaminergic transmission mediated by serotonergic neurons in L-DOPA-induced dyskinesia. Parkinsons Dis 2012, 2012:1-16.
21. Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology 2009, 72:S1-S136.
22. O'Sullivan S.S., Williams D.R., Gallagher D.A., Massey L.A., Silveira-Moriyama L., Lees A.J. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008, 23:101-106.
23. Parent M., Wallman M.J., Gagnon D., Parent A. Serotonin innervation of basal ganglia in monkeys and humans. J Chem Neuroanat 2011, 41:256-265.
24. Paulus W., Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991, 50:743-755.
25. Politis M., Wu K., Loane C., Kiferle L., Molloy S., Brooks D.J., et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis 2010, 40:216-221.
26. Ramamoorthy S., Blakely R.D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 1999, 285:763-766.
27. Ramamoorthy S., Giovanetti E., Qian Y., Blakely R.D. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 1998, 273:2458-2466.
28. Reimold M., Batra A., Knobel A., Smolka M.N., Zimmer A., Mann K., et al. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol Psychiatry 2008, 13:606-613. [557].
29. Rylander D., Parent M., O'Sullivan S.S., Dovero S., Lees A.J., Bezard E., et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 2010, 68:619-628.
30. Sanchez M.G., Bourque M., Morissette M., Di Paolo T. Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 2010, 16:e43-e71.
31. Sanchez M.G., Estrada-Camarena E., Belanger N., Morissette M., Di Paolo T. Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy. Neuropharmacology 2011, 60:642-652.
32. Sanchez M.G., Morissette M., Di Paolo T. Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J Neuroendocrinol 2013, 25:560-569.
33. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat Rev Endocrinol 2009, 5:620-627.
34. Shively C.A., Mirkes S.J., Lu N.Z., Henderson J.A., Bethea C.L. Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J 2003, 3:114-121.
35. Strecker K., Wegner F., Hesse S., Becker G.A., Patt M., Meyer P.M., et al. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter. J Neurol 2011, 258:19-26.
36. Wang J.L., Oya S., Parhi A.K., Lieberman B.P., Ploessl K., Hou C., et al. In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. Nucl Med Biol 2010, 37:479-486.